Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-16007876Phase 4Completed
Phase 4, randomised, double-blind trial of ropivacaine, bupivacaine and lidocaine in diabetic retinopathy (DR), retinal detachment, central retinal vein occlusion (CRVO) and 5 more (4 arms), sponsored by Xinhua Hospital. Primary endpoints: Time of onset of analgesia, Time of onset of akinesia and 1 more. Started Dec 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-16007876.